Sk Bioscience Co., Ltd.
Clinical trials sponsored by Sk Bioscience Co., Ltd., explained in plain language.
South Korean vaccine and biopharmaceutical company.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New vaccine aims to shield against multiple coronavirus types
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine called GBP511, designed to protect against several sarbecoviruses (a group that includes SARS-CoV-2). About 368 healthy adults will receive one or two doses at different strengths, with or without an adjuvant to boost immune response. The goal is to…
Phase: PHASE1, PHASE2 • Sponsor: SK Bioscience Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:33 UTC
-
New mRNA vaccine targets brain infection in global trial
⭐️ VACCINE ⭐️ Recruiting nowThis study tests two new mRNA vaccines (GBP560) against Japanese encephalitis, a virus that can cause brain swelling. About 402 healthy adults will receive different doses of the vaccine or a comparison vaccine. Researchers will monitor safety and measure immune responses to find…
Phase: PHASE1, PHASE2 • Sponsor: SK Bioscience Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:06 UTC